KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other Non-Current Liabilities (2017 - 2025)

Historic Other Non-Current Liabilities for Neogenomics (NEO) over the last 10 years, with Q4 2025 value amounting to $12.1 million.

  • Neogenomics' Other Non-Current Liabilities rose 252.29% to $12.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.1 million, marking a year-over-year increase of 252.29%. This contributed to the annual value of $12.1 million for FY2025, which is 252.29% up from last year.
  • Latest data reveals that Neogenomics reported Other Non-Current Liabilities of $12.1 million as of Q4 2025, which was up 252.29% from $12.0 million recorded in Q3 2025.
  • Over the past 5 years, Neogenomics' Other Non-Current Liabilities peaked at $14.4 million during Q3 2021, and registered a low of $3.7 million during Q1 2021.
  • In the last 5 years, Neogenomics' Other Non-Current Liabilities had a median value of $13.0 million in 2023 and averaged $12.0 million.
  • As far as peak fluctuations go, Neogenomics' Other Non-Current Liabilities crashed by 1246.75% in 2021, and later skyrocketed by 28146.75% in 2022.
  • Neogenomics' Other Non-Current Liabilities (Quarter) stood at $14.0 million in 2021, then decreased by 6.9% to $13.1 million in 2022, then dropped by 0.16% to $13.0 million in 2023, then fell by 9.68% to $11.8 million in 2024, then grew by 2.52% to $12.1 million in 2025.
  • Its Other Non-Current Liabilities was $12.1 million in Q4 2025, compared to $12.0 million in Q3 2025 and $12.1 million in Q2 2025.